Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial von Margolin, Kim, Prof, Ernstoff, Marc S, MD, Hamid, Omid, MD, Lawrence, Donald, MD, McDermott, David, MD, Puzanov, Igor, MD, Wolchok, Jedd D, MD, Clark, Joseph I, Prof, Sznol, Mario, MD, Logan, Theodore F, MD, Richards, Jon, MD, Michener, Tracy, PharmD, Balogh, Agnes, MS, Heller, Kevin N, MD, Hodi, F Stephen, MD

Volltext

Virus-specific CD4+ T cells: ready for direct attack von Heller, Kevin N, Gurer, Cagan, Münz, Christian

Volltext

Case Report: response to ipilimumab in a patient with HIV with metastatic melanoma von Burke, Matthew M, Kluger, Harriet M, Golden, Marjorie, Heller, Kevin N, Hoos, Axel, Sznol, Mario

Volltext

743 INCLINE-101: preliminary safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TAC-001 (TLR9 agonist conjugated to a CD22 mAb) in patients with advanced or... von Perez, Cesar, Henry, Jason, Kim, Sunnie, El-Khoueiry, Anthony, Gutierrez, Martin, Pavlick, Anna, Lee, Joshua, Bollini, Sangeetha, Jin, Feng, Harrabi, Ons, Heller, Kevin N, Humphries, Timothy

Volltext

Patients with Epstein Barr virus‐positive lymphomas have decreased CD4+ T‐cell responses to the viral nuclear antigen 1 von Heller, Kevin N., Arrey, Frida, Steinherz, Peter, Portlock, Carol, Chadburn, Amy, Kelly, Kara, Münz, Christian

Volltext

Children with endemic Burkitt lymphoma are deficient in EBNA1‐specific IFN‐γ T cell responses von Moormann, Ann M., Heller, Kevin N., Chelimo, Kiprotich, Embury, Paula, Ploutz‐Snyder, Robert, Otieno, Juliana A., Oduor, Margaret, Münz, Christian, Rochford, Rosemary

Volltext

Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers von Heller, Kevin N., Upshaw, Jenica, Seyoum, Beza, Zebroski, Henry, Münz, Christian

Volltext

Effect of an Outreach Programme on Vandetanib Safety in Medullary Thyroid Cancer von Bastholt, Lars, Kreissl, Michael C., Führer, Dagmar, Maia, Ana L., Locati, Laura D., Maciel, Léa, Wu, Yi, Heller, Kevin N., Webster, Alan, Elisei, Rossella

Volltext

Food Increased the Bioavailability of BMS-690514, an Orally Active EGFR/HER2/VEGF Receptor Kinase Inhibitor, in Healthy Subjects von Vakkalagadda, Blisse, Park, Jong-Soon, Ahlers, Christoph M., Dorizio, Stephanie, Has, Teresa, Roongta, Vikram, Heller, Kevin N., Derbin, George M., Zhang, Steven

Volltext

Primary follicular lymphoma of the testis: excellent outcome following surgical resection without adjuvant chemotherapy von Heller, Kevin N, Teruya-Feldstein, Julie, La Quaglia, Michael P, Wexler, Leonard H

Volltext

JSP191 As a Single-Agent Conditioning Regimen Results in Successful Engraftment, Donor Myeloid Chimerism, and Production of Donor Derived Naïve Lymphocytes in Patients with Severe... von Agarwal, Rajni, Dvorak, Christopher C., Prockop, Susan, Kwon, Hye-Sook, Long-Boyle, Janel R, Le, Anne, Brown, Janice W, Merkel, Elisabeth, Truong, Kenny, Velasco, Brenda, Arulprakasam, Kavitha, Harada, Nicole, Dougall, Kirstin A, Prohaska, Susan S, Pang, Wendy W, Heller, Kevin N., Weissman, Irving L, Cowan, Morton J, Logan, Aaron C., O'Reilly, Richard J, Parkman, Robertson, Weinberg, Ken I., Roncarolo, Maria Grazia, Shizuru, Judith A

Volltext

Trial in progress: A phase I/II, open-label, dose-escalation, safety and tolerability study of NC318 in subjects with advanced or metastatic solid tumors von Gutierrez, Martin, Hamid, Omid, Shum, Elaine, Wise, David R, Balar, Arjun Vasant, Weber, Jeffrey S., LoRusso, Patricia, Shafi, Saba, Rimm, David L., Tolcher, Anthony W., Basudhar, Debashree, Dujka, Melanie Elizabeth, Heller, Kevin N.

Volltext

Abstract 3643: INCAGN1876, a unique GITR agonist antibody that facilitates GITR oligomerization von Gonzalez, Ana M., Manrique, Mariana L., Swiech, Lukasz, Horn, Thomas, Waight, Jeremy, Liu, Yuqi, Lin, Shiwen, Underwood, Dennis, Breous, Ekaterina, Leger, Olivier, Seibert, Volker, Merghoub, Taha, Zappasodi, Roberta, Ritter, Gerd, Schaer, David, Heller, Kevin N., Brill, Kimberli, Scherle, Peggy, Hollis, Gregory, Huber, Reid, Dijk, Marc van, Buell, Jennifer, Stein, Robert, Wilson, Nicholas S.

Volltext

LBA4 - Preliminary Data from a Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning Is Well-Tolerated,... von Muffly, Lori, Lee, Catherine J., Gandhi, Arpita, Varma, Ankur, Scott, Bart L., Kwon, Hye-Sook, Yanagiba, Chikako, Arulprakasam, Jeyakavitha, Reddy, Mamatha, Heller, Kevin N., Shizuru, Judith A., Pang, Wendy W., Artz, Andrew

Volltext

Preliminary Data from a Phase 1 Study of JSP191, an Anti-CD117 Monoclonal Antibody, in Combination with Low Dose Irradiation and Fludarabine Conditioning Is Well-Tolerated, Facilit... von Muffly, Lori, Lee, Catherine J., Gandhi, Arpita, Varma, Ankur, Scott, Bart L., Kwon, Hye-Sook, Yanagiba, Chikako, Arulprakasam, Jeyakavitha, Reddy, Mamatha, Heller, Kevin N., Shizuru, Judith A., Pang, Wendy W., Artz, Andrew

Volltext

Malignant osteoclast-like giant cell tumor of the kidney von Heller, Kevin N., Manyak, Michael J., Tabbara, Sana O., Kerr, Lindsey A.

Volltext

Virus-specific CD4 super(+) T cells: ready for direct attack von Heller, Kevin N, Gurer, Cagan, Muenz, Christian

Volltext

Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-g T cell responses von Moormann, Ann M, Heller, Kevin N, Chelimo, Kiprotich, Embury, Paula, Ploutz-Snyder, Robert, Otieno, Juliana A, Oduor, Margaret, Munz, Christian, Rochford, Rosemary

Volltext

COMBINATION THERAPY OF ANTI-PD-1 ACTIVE AGENT, ANTI-TIM-3 ACTIVE AGENT, AND ANTI-LAG-3 ACTIVE AGENT FOR TREATING CANCER von HELLER, Kevin N, DONG, Zhiwan, SRINIVASAN, Nithya, HOYLE, Paul E, CONDAMINE, Thomas, JANIK, John E

Volltext bestellen

COMBINATION THERAPY OF ANTI-PD-1 ACTIVE AGENT, ANTI-TIM-3 ACTIVE AGENT, AND ANTI-LAG-3 ACTIVE AGENT FOR TREATING CANCER von HELLER, Kevin N, DONG, Zhiwan, SRINIVASAN, Nithya, HOYLE, Paul E, CONDAMINE, Thomas, JANIK, John E

Volltext bestellen